nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—UGT1A9—Irinotecan—pancreatic cancer	0.515	1	CbGbCtD
Entacapone—Body temperature increased—Fluorouracil—pancreatic cancer	0.000299	0.000615	CcSEcCtD
Entacapone—Palpitations—Docetaxel—pancreatic cancer	0.000295	0.000608	CcSEcCtD
Entacapone—Weight increased—Epirubicin—pancreatic cancer	0.000294	0.000606	CcSEcCtD
Entacapone—Loss of consciousness—Docetaxel—pancreatic cancer	0.000294	0.000605	CcSEcCtD
Entacapone—Weight decreased—Epirubicin—pancreatic cancer	0.000293	0.000603	CcSEcCtD
Entacapone—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000292	0.000601	CcSEcCtD
Entacapone—Cough—Docetaxel—pancreatic cancer	0.000292	0.000601	CcSEcCtD
Entacapone—Angina pectoris—Doxorubicin—pancreatic cancer	0.000292	0.000601	CcSEcCtD
Entacapone—Hypersensitivity—Irinotecan—pancreatic cancer	0.000291	0.000599	CcSEcCtD
Entacapone—Pneumonia—Epirubicin—pancreatic cancer	0.00029	0.000598	CcSEcCtD
Entacapone—Convulsion—Docetaxel—pancreatic cancer	0.00029	0.000596	CcSEcCtD
Entacapone—Hypertension—Docetaxel—pancreatic cancer	0.000288	0.000594	CcSEcCtD
Entacapone—Chest pain—Docetaxel—pancreatic cancer	0.000284	0.000586	CcSEcCtD
Entacapone—Myalgia—Docetaxel—pancreatic cancer	0.000284	0.000586	CcSEcCtD
Entacapone—Nausea—Sunitinib—pancreatic cancer	0.000284	0.000586	CcSEcCtD
Entacapone—Asthenia—Irinotecan—pancreatic cancer	0.000283	0.000583	CcSEcCtD
Entacapone—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000283	0.000582	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000283	0.000582	CcSEcCtD
Entacapone—Urinary tract infection—Epirubicin—pancreatic cancer	0.00028	0.000578	CcSEcCtD
Entacapone—Conjunctivitis—Epirubicin—pancreatic cancer	0.00028	0.000578	CcSEcCtD
Entacapone—Dysuria—Doxorubicin—pancreatic cancer	0.00028	0.000577	CcSEcCtD
Entacapone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000278	0.000574	CcSEcCtD
Entacapone—Dry mouth—Docetaxel—pancreatic cancer	0.000278	0.000573	CcSEcCtD
Entacapone—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000278	0.000573	CcSEcCtD
Entacapone—Sweating—Epirubicin—pancreatic cancer	0.000276	0.00057	CcSEcCtD
Entacapone—Pollakiuria—Doxorubicin—pancreatic cancer	0.000276	0.00057	CcSEcCtD
Entacapone—Asthenia—Gemcitabine—pancreatic cancer	0.000276	0.000568	CcSEcCtD
Entacapone—Haematuria—Epirubicin—pancreatic cancer	0.000275	0.000567	CcSEcCtD
Entacapone—Confusional state—Docetaxel—pancreatic cancer	0.000275	0.000567	CcSEcCtD
Entacapone—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000273	0.000562	CcSEcCtD
Entacapone—Oedema—Docetaxel—pancreatic cancer	0.000273	0.000562	CcSEcCtD
Entacapone—Weight increased—Doxorubicin—pancreatic cancer	0.000272	0.000561	CcSEcCtD
Entacapone—Epistaxis—Epirubicin—pancreatic cancer	0.000272	0.00056	CcSEcCtD
Entacapone—Pruritus—Gemcitabine—pancreatic cancer	0.000272	0.00056	CcSEcCtD
Entacapone—Weight decreased—Doxorubicin—pancreatic cancer	0.000271	0.000558	CcSEcCtD
Entacapone—Sinusitis—Epirubicin—pancreatic cancer	0.000271	0.000557	CcSEcCtD
Entacapone—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.00027	0.000556	CcSEcCtD
Entacapone—Diarrhoea—Irinotecan—pancreatic cancer	0.00027	0.000556	CcSEcCtD
Entacapone—Agranulocytosis—Epirubicin—pancreatic cancer	0.000269	0.000554	CcSEcCtD
Entacapone—Pneumonia—Doxorubicin—pancreatic cancer	0.000268	0.000553	CcSEcCtD
Entacapone—Shock—Docetaxel—pancreatic cancer	0.000268	0.000553	CcSEcCtD
Entacapone—Nervous system disorder—Docetaxel—pancreatic cancer	0.000267	0.000551	CcSEcCtD
Entacapone—Pruritus—Fluorouracil—pancreatic cancer	0.000267	0.000551	CcSEcCtD
Entacapone—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000267	0.00055	CcSEcCtD
Entacapone—Skin disorder—Docetaxel—pancreatic cancer	0.000265	0.000546	CcSEcCtD
Entacapone—Bradycardia—Epirubicin—pancreatic cancer	0.000264	0.000543	CcSEcCtD
Entacapone—Diarrhoea—Gemcitabine—pancreatic cancer	0.000263	0.000542	CcSEcCtD
Entacapone—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000262	0.000539	CcSEcCtD
Entacapone—Dizziness—Irinotecan—pancreatic cancer	0.000261	0.000537	CcSEcCtD
Entacapone—Haemoglobin—Epirubicin—pancreatic cancer	0.00026	0.000536	CcSEcCtD
Entacapone—Anorexia—Docetaxel—pancreatic cancer	0.00026	0.000536	CcSEcCtD
Entacapone—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000259	0.000534	CcSEcCtD
Entacapone—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000259	0.000534	CcSEcCtD
Entacapone—Haemorrhage—Epirubicin—pancreatic cancer	0.000259	0.000533	CcSEcCtD
Entacapone—Hepatitis—Epirubicin—pancreatic cancer	0.000259	0.000533	CcSEcCtD
Entacapone—Diarrhoea—Fluorouracil—pancreatic cancer	0.000259	0.000533	CcSEcCtD
Entacapone—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000258	0.000531	CcSEcCtD
Entacapone—Pharyngitis—Epirubicin—pancreatic cancer	0.000257	0.000529	CcSEcCtD
Entacapone—Sweating—Doxorubicin—pancreatic cancer	0.000256	0.000527	CcSEcCtD
Entacapone—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000256	0.000527	CcSEcCtD
Entacapone—Hypotension—Docetaxel—pancreatic cancer	0.000255	0.000525	CcSEcCtD
Entacapone—Haematuria—Doxorubicin—pancreatic cancer	0.000254	0.000524	CcSEcCtD
Entacapone—Urethral disorder—Epirubicin—pancreatic cancer	0.000254	0.000523	CcSEcCtD
Entacapone—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000252	0.00052	CcSEcCtD
Entacapone—Epistaxis—Doxorubicin—pancreatic cancer	0.000252	0.000519	CcSEcCtD
Entacapone—Vomiting—Irinotecan—pancreatic cancer	0.000251	0.000517	CcSEcCtD
Entacapone—Sinusitis—Doxorubicin—pancreatic cancer	0.00025	0.000516	CcSEcCtD
Entacapone—Dizziness—Fluorouracil—pancreatic cancer	0.00025	0.000515	CcSEcCtD
Entacapone—Visual impairment—Epirubicin—pancreatic cancer	0.00025	0.000514	CcSEcCtD
Entacapone—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000249	0.000513	CcSEcCtD
Entacapone—Rash—Irinotecan—pancreatic cancer	0.000249	0.000512	CcSEcCtD
Entacapone—Dermatitis—Irinotecan—pancreatic cancer	0.000249	0.000512	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000248	0.000512	CcSEcCtD
Entacapone—Headache—Irinotecan—pancreatic cancer	0.000247	0.000509	CcSEcCtD
Entacapone—Insomnia—Docetaxel—pancreatic cancer	0.000247	0.000508	CcSEcCtD
Entacapone—Paraesthesia—Docetaxel—pancreatic cancer	0.000245	0.000505	CcSEcCtD
Entacapone—Erythema multiforme—Epirubicin—pancreatic cancer	0.000245	0.000504	CcSEcCtD
Entacapone—Vomiting—Gemcitabine—pancreatic cancer	0.000244	0.000503	CcSEcCtD
Entacapone—Bradycardia—Doxorubicin—pancreatic cancer	0.000244	0.000502	CcSEcCtD
Entacapone—Dyspnoea—Docetaxel—pancreatic cancer	0.000243	0.000501	CcSEcCtD
Entacapone—Somnolence—Docetaxel—pancreatic cancer	0.000242	0.000499	CcSEcCtD
Entacapone—Rash—Gemcitabine—pancreatic cancer	0.000242	0.000499	CcSEcCtD
Entacapone—Dermatitis—Gemcitabine—pancreatic cancer	0.000242	0.000499	CcSEcCtD
Entacapone—Eye disorder—Epirubicin—pancreatic cancer	0.000242	0.000498	CcSEcCtD
Entacapone—Haemoglobin—Doxorubicin—pancreatic cancer	0.000241	0.000496	CcSEcCtD
Entacapone—Headache—Gemcitabine—pancreatic cancer	0.000241	0.000496	CcSEcCtD
Entacapone—Flushing—Epirubicin—pancreatic cancer	0.00024	0.000495	CcSEcCtD
Entacapone—Cardiac disorder—Epirubicin—pancreatic cancer	0.00024	0.000495	CcSEcCtD
Entacapone—Vomiting—Fluorouracil—pancreatic cancer	0.00024	0.000495	CcSEcCtD
Entacapone—Dyspepsia—Docetaxel—pancreatic cancer	0.00024	0.000495	CcSEcCtD
Entacapone—Hepatitis—Doxorubicin—pancreatic cancer	0.00024	0.000494	CcSEcCtD
Entacapone—Haemorrhage—Doxorubicin—pancreatic cancer	0.00024	0.000494	CcSEcCtD
Entacapone—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000238	0.000491	CcSEcCtD
Entacapone—Rash—Fluorouracil—pancreatic cancer	0.000238	0.000491	CcSEcCtD
Entacapone—Dermatitis—Fluorouracil—pancreatic cancer	0.000238	0.00049	CcSEcCtD
Entacapone—Pharyngitis—Doxorubicin—pancreatic cancer	0.000238	0.00049	CcSEcCtD
Entacapone—Decreased appetite—Docetaxel—pancreatic cancer	0.000237	0.000488	CcSEcCtD
Entacapone—Headache—Fluorouracil—pancreatic cancer	0.000237	0.000488	CcSEcCtD
Entacapone—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000237	0.000487	CcSEcCtD
Entacapone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000235	0.000485	CcSEcCtD
Entacapone—Fatigue—Docetaxel—pancreatic cancer	0.000235	0.000484	CcSEcCtD
Entacapone—Urethral disorder—Doxorubicin—pancreatic cancer	0.000235	0.000484	CcSEcCtD
Entacapone—Nausea—Irinotecan—pancreatic cancer	0.000234	0.000483	CcSEcCtD
Entacapone—Pain—Docetaxel—pancreatic cancer	0.000233	0.00048	CcSEcCtD
Entacapone—Constipation—Docetaxel—pancreatic cancer	0.000233	0.00048	CcSEcCtD
Entacapone—Visual impairment—Doxorubicin—pancreatic cancer	0.000231	0.000476	CcSEcCtD
Entacapone—Alopecia—Epirubicin—pancreatic cancer	0.000229	0.000471	CcSEcCtD
Entacapone—Nausea—Gemcitabine—pancreatic cancer	0.000228	0.00047	CcSEcCtD
Entacapone—Mental disorder—Epirubicin—pancreatic cancer	0.000227	0.000467	CcSEcCtD
Entacapone—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000227	0.000467	CcSEcCtD
Entacapone—Malnutrition—Epirubicin—pancreatic cancer	0.000225	0.000464	CcSEcCtD
Entacapone—Feeling abnormal—Docetaxel—pancreatic cancer	0.000225	0.000463	CcSEcCtD
Entacapone—Nausea—Fluorouracil—pancreatic cancer	0.000224	0.000462	CcSEcCtD
Entacapone—Eye disorder—Doxorubicin—pancreatic cancer	0.000224	0.000461	CcSEcCtD
Entacapone—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000223	0.000459	CcSEcCtD
Entacapone—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000222	0.000458	CcSEcCtD
Entacapone—Flushing—Doxorubicin—pancreatic cancer	0.000222	0.000458	CcSEcCtD
Entacapone—Flatulence—Epirubicin—pancreatic cancer	0.000222	0.000458	CcSEcCtD
Entacapone—Tension—Epirubicin—pancreatic cancer	0.000221	0.000456	CcSEcCtD
Entacapone—Dysgeusia—Epirubicin—pancreatic cancer	0.000221	0.000455	CcSEcCtD
Entacapone—Nervousness—Epirubicin—pancreatic cancer	0.000219	0.000451	CcSEcCtD
Entacapone—Back pain—Epirubicin—pancreatic cancer	0.000218	0.000449	CcSEcCtD
Entacapone—Muscle spasms—Epirubicin—pancreatic cancer	0.000217	0.000446	CcSEcCtD
Entacapone—Abdominal pain—Docetaxel—pancreatic cancer	0.000216	0.000444	CcSEcCtD
Entacapone—Body temperature increased—Docetaxel—pancreatic cancer	0.000216	0.000444	CcSEcCtD
Entacapone—Vision blurred—Epirubicin—pancreatic cancer	0.000212	0.000438	CcSEcCtD
Entacapone—Alopecia—Doxorubicin—pancreatic cancer	0.000212	0.000436	CcSEcCtD
Entacapone—Mental disorder—Doxorubicin—pancreatic cancer	0.00021	0.000432	CcSEcCtD
Entacapone—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000209	0.000431	CcSEcCtD
Entacapone—Malnutrition—Doxorubicin—pancreatic cancer	0.000209	0.00043	CcSEcCtD
Entacapone—Agitation—Epirubicin—pancreatic cancer	0.000207	0.000427	CcSEcCtD
Entacapone—Flatulence—Doxorubicin—pancreatic cancer	0.000205	0.000423	CcSEcCtD
Entacapone—Tension—Doxorubicin—pancreatic cancer	0.000205	0.000422	CcSEcCtD
Entacapone—Dysgeusia—Doxorubicin—pancreatic cancer	0.000204	0.000421	CcSEcCtD
Entacapone—Malaise—Epirubicin—pancreatic cancer	0.000203	0.000419	CcSEcCtD
Entacapone—Nervousness—Doxorubicin—pancreatic cancer	0.000203	0.000417	CcSEcCtD
Entacapone—Vertigo—Epirubicin—pancreatic cancer	0.000202	0.000417	CcSEcCtD
Entacapone—Syncope—Epirubicin—pancreatic cancer	0.000202	0.000416	CcSEcCtD
Entacapone—Leukopenia—Epirubicin—pancreatic cancer	0.000202	0.000416	CcSEcCtD
Entacapone—Back pain—Doxorubicin—pancreatic cancer	0.000202	0.000416	CcSEcCtD
Entacapone—Hypersensitivity—Docetaxel—pancreatic cancer	0.000201	0.000414	CcSEcCtD
Entacapone—Muscle spasms—Doxorubicin—pancreatic cancer	0.0002	0.000413	CcSEcCtD
Entacapone—Palpitations—Epirubicin—pancreatic cancer	0.000199	0.00041	CcSEcCtD
Entacapone—Loss of consciousness—Epirubicin—pancreatic cancer	0.000198	0.000408	CcSEcCtD
Entacapone—Cough—Epirubicin—pancreatic cancer	0.000197	0.000405	CcSEcCtD
Entacapone—Vision blurred—Doxorubicin—pancreatic cancer	0.000197	0.000405	CcSEcCtD
Entacapone—Asthenia—Docetaxel—pancreatic cancer	0.000196	0.000403	CcSEcCtD
Entacapone—Convulsion—Epirubicin—pancreatic cancer	0.000195	0.000402	CcSEcCtD
Entacapone—Hypertension—Epirubicin—pancreatic cancer	0.000195	0.000401	CcSEcCtD
Entacapone—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000193	0.000399	CcSEcCtD
Entacapone—Pruritus—Docetaxel—pancreatic cancer	0.000193	0.000398	CcSEcCtD
Entacapone—Myalgia—Epirubicin—pancreatic cancer	0.000192	0.000395	CcSEcCtD
Entacapone—Chest pain—Epirubicin—pancreatic cancer	0.000192	0.000395	CcSEcCtD
Entacapone—Agitation—Doxorubicin—pancreatic cancer	0.000192	0.000395	CcSEcCtD
Entacapone—Anxiety—Epirubicin—pancreatic cancer	0.000191	0.000394	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000191	0.000393	CcSEcCtD
Entacapone—Discomfort—Epirubicin—pancreatic cancer	0.00019	0.000391	CcSEcCtD
Entacapone—Malaise—Doxorubicin—pancreatic cancer	0.000188	0.000387	CcSEcCtD
Entacapone—Dry mouth—Epirubicin—pancreatic cancer	0.000188	0.000387	CcSEcCtD
Entacapone—Vertigo—Doxorubicin—pancreatic cancer	0.000187	0.000386	CcSEcCtD
Entacapone—Syncope—Doxorubicin—pancreatic cancer	0.000187	0.000385	CcSEcCtD
Entacapone—Leukopenia—Doxorubicin—pancreatic cancer	0.000187	0.000385	CcSEcCtD
Entacapone—Diarrhoea—Docetaxel—pancreatic cancer	0.000187	0.000384	CcSEcCtD
Entacapone—Confusional state—Epirubicin—pancreatic cancer	0.000185	0.000382	CcSEcCtD
Entacapone—Palpitations—Doxorubicin—pancreatic cancer	0.000184	0.00038	CcSEcCtD
Entacapone—Oedema—Epirubicin—pancreatic cancer	0.000184	0.000379	CcSEcCtD
Entacapone—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000183	0.000378	CcSEcCtD
Entacapone—Cough—Doxorubicin—pancreatic cancer	0.000182	0.000375	CcSEcCtD
Entacapone—Shock—Epirubicin—pancreatic cancer	0.000181	0.000373	CcSEcCtD
Entacapone—Convulsion—Doxorubicin—pancreatic cancer	0.000181	0.000372	CcSEcCtD
Entacapone—Nervous system disorder—Epirubicin—pancreatic cancer	0.00018	0.000372	CcSEcCtD
Entacapone—Dizziness—Docetaxel—pancreatic cancer	0.00018	0.000372	CcSEcCtD
Entacapone—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00018	0.000371	CcSEcCtD
Entacapone—Hypertension—Doxorubicin—pancreatic cancer	0.00018	0.000371	CcSEcCtD
Entacapone—Skin disorder—Epirubicin—pancreatic cancer	0.000179	0.000368	CcSEcCtD
Entacapone—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000178	0.000366	CcSEcCtD
Entacapone—Chest pain—Doxorubicin—pancreatic cancer	0.000178	0.000366	CcSEcCtD
Entacapone—Myalgia—Doxorubicin—pancreatic cancer	0.000178	0.000366	CcSEcCtD
Entacapone—Anxiety—Doxorubicin—pancreatic cancer	0.000177	0.000365	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000176	0.000363	CcSEcCtD
Entacapone—Discomfort—Doxorubicin—pancreatic cancer	0.000175	0.000361	CcSEcCtD
Entacapone—Anorexia—Epirubicin—pancreatic cancer	0.000175	0.000361	CcSEcCtD
Entacapone—Dry mouth—Doxorubicin—pancreatic cancer	0.000174	0.000358	CcSEcCtD
Entacapone—Vomiting—Docetaxel—pancreatic cancer	0.000173	0.000357	CcSEcCtD
Entacapone—Rash—Docetaxel—pancreatic cancer	0.000172	0.000354	CcSEcCtD
Entacapone—Hypotension—Epirubicin—pancreatic cancer	0.000172	0.000354	CcSEcCtD
Entacapone—Dermatitis—Docetaxel—pancreatic cancer	0.000172	0.000354	CcSEcCtD
Entacapone—Confusional state—Doxorubicin—pancreatic cancer	0.000172	0.000354	CcSEcCtD
Entacapone—Headache—Docetaxel—pancreatic cancer	0.000171	0.000352	CcSEcCtD
Entacapone—Oedema—Doxorubicin—pancreatic cancer	0.00017	0.000351	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000168	0.000345	CcSEcCtD
Entacapone—Shock—Doxorubicin—pancreatic cancer	0.000167	0.000345	CcSEcCtD
Entacapone—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000167	0.000344	CcSEcCtD
Entacapone—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000167	0.000343	CcSEcCtD
Entacapone—Insomnia—Epirubicin—pancreatic cancer	0.000166	0.000343	CcSEcCtD
Entacapone—Skin disorder—Doxorubicin—pancreatic cancer	0.000165	0.000341	CcSEcCtD
Entacapone—Paraesthesia—Epirubicin—pancreatic cancer	0.000165	0.00034	CcSEcCtD
Entacapone—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000165	0.000339	CcSEcCtD
Entacapone—Dyspnoea—Epirubicin—pancreatic cancer	0.000164	0.000338	CcSEcCtD
Entacapone—Somnolence—Epirubicin—pancreatic cancer	0.000164	0.000337	CcSEcCtD
Entacapone—Anorexia—Doxorubicin—pancreatic cancer	0.000162	0.000334	CcSEcCtD
Entacapone—Nausea—Docetaxel—pancreatic cancer	0.000162	0.000334	CcSEcCtD
Entacapone—Dyspepsia—Epirubicin—pancreatic cancer	0.000162	0.000334	CcSEcCtD
Entacapone—Decreased appetite—Epirubicin—pancreatic cancer	0.00016	0.000329	CcSEcCtD
Entacapone—Hypotension—Doxorubicin—pancreatic cancer	0.000159	0.000328	CcSEcCtD
Entacapone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000159	0.000327	CcSEcCtD
Entacapone—Fatigue—Epirubicin—pancreatic cancer	0.000159	0.000327	CcSEcCtD
Entacapone—Pain—Epirubicin—pancreatic cancer	0.000157	0.000324	CcSEcCtD
Entacapone—Constipation—Epirubicin—pancreatic cancer	0.000157	0.000324	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000155	0.000319	CcSEcCtD
Entacapone—Insomnia—Doxorubicin—pancreatic cancer	0.000154	0.000317	CcSEcCtD
Entacapone—Paraesthesia—Doxorubicin—pancreatic cancer	0.000153	0.000315	CcSEcCtD
Entacapone—Dyspnoea—Doxorubicin—pancreatic cancer	0.000152	0.000313	CcSEcCtD
Entacapone—Feeling abnormal—Epirubicin—pancreatic cancer	0.000152	0.000312	CcSEcCtD
Entacapone—Somnolence—Doxorubicin—pancreatic cancer	0.000151	0.000312	CcSEcCtD
Entacapone—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00015	0.00031	CcSEcCtD
Entacapone—Dyspepsia—Doxorubicin—pancreatic cancer	0.00015	0.000309	CcSEcCtD
Entacapone—Decreased appetite—Doxorubicin—pancreatic cancer	0.000148	0.000305	CcSEcCtD
Entacapone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000147	0.000303	CcSEcCtD
Entacapone—Fatigue—Doxorubicin—pancreatic cancer	0.000147	0.000302	CcSEcCtD
Entacapone—Urticaria—Epirubicin—pancreatic cancer	0.000146	0.000301	CcSEcCtD
Entacapone—Pain—Doxorubicin—pancreatic cancer	0.000146	0.0003	CcSEcCtD
Entacapone—Constipation—Doxorubicin—pancreatic cancer	0.000146	0.0003	CcSEcCtD
Entacapone—Abdominal pain—Epirubicin—pancreatic cancer	0.000145	0.0003	CcSEcCtD
Entacapone—Body temperature increased—Epirubicin—pancreatic cancer	0.000145	0.0003	CcSEcCtD
Entacapone—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00014	0.000289	CcSEcCtD
Entacapone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000139	0.000287	CcSEcCtD
Entacapone—Hypersensitivity—Epirubicin—pancreatic cancer	0.000136	0.000279	CcSEcCtD
Entacapone—Urticaria—Doxorubicin—pancreatic cancer	0.000135	0.000279	CcSEcCtD
Entacapone—Body temperature increased—Doxorubicin—pancreatic cancer	0.000135	0.000277	CcSEcCtD
Entacapone—Abdominal pain—Doxorubicin—pancreatic cancer	0.000135	0.000277	CcSEcCtD
Entacapone—Asthenia—Epirubicin—pancreatic cancer	0.000132	0.000272	CcSEcCtD
Entacapone—Pruritus—Epirubicin—pancreatic cancer	0.00013	0.000268	CcSEcCtD
Entacapone—Diarrhoea—Epirubicin—pancreatic cancer	0.000126	0.000259	CcSEcCtD
Entacapone—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000125	0.000258	CcSEcCtD
Entacapone—Asthenia—Doxorubicin—pancreatic cancer	0.000122	0.000252	CcSEcCtD
Entacapone—Dizziness—Epirubicin—pancreatic cancer	0.000122	0.000251	CcSEcCtD
Entacapone—Pruritus—Doxorubicin—pancreatic cancer	0.00012	0.000248	CcSEcCtD
Entacapone—Vomiting—Epirubicin—pancreatic cancer	0.000117	0.000241	CcSEcCtD
Entacapone—Diarrhoea—Doxorubicin—pancreatic cancer	0.000116	0.00024	CcSEcCtD
Entacapone—Rash—Epirubicin—pancreatic cancer	0.000116	0.000239	CcSEcCtD
Entacapone—Dermatitis—Epirubicin—pancreatic cancer	0.000116	0.000239	CcSEcCtD
Entacapone—Headache—Epirubicin—pancreatic cancer	0.000115	0.000237	CcSEcCtD
Entacapone—Dizziness—Doxorubicin—pancreatic cancer	0.000113	0.000232	CcSEcCtD
Entacapone—Nausea—Epirubicin—pancreatic cancer	0.000109	0.000225	CcSEcCtD
Entacapone—Vomiting—Doxorubicin—pancreatic cancer	0.000108	0.000223	CcSEcCtD
Entacapone—Rash—Doxorubicin—pancreatic cancer	0.000107	0.000221	CcSEcCtD
Entacapone—Dermatitis—Doxorubicin—pancreatic cancer	0.000107	0.000221	CcSEcCtD
Entacapone—Headache—Doxorubicin—pancreatic cancer	0.000107	0.00022	CcSEcCtD
Entacapone—Nausea—Doxorubicin—pancreatic cancer	0.000101	0.000208	CcSEcCtD
